In 200 extremely preterm infants (<28 weeks) with patent ductus arteriosus analysed at 24 months' corrected age, survival without neurodevelopmental impairment did not differ between expectant management and early ibuprofen (49% vs 49%; RR 1.00, 95% CI 0.76-1.33).
RCTn = 273
Apers et al. Long-Term Outcomes of Expectant Management versus Early Ibuprofen for Patent Ductus Arteriosus: 24-Month Follow-Up of the BeNeDuctus Trial